The Genetics Society of Korea

Recent papers from The Genetics Society of Korea

1. Real-world safety of FF/UMEC/VI in patients with asthma or COPD, and clinical outcomes in COPD: post-marketing surveillance in KoreaTuberculosis & respiratory diseases · 2026
2. Closing the Gap in Pre-Exposure Prophylaxis Access for Sexual and Gender Minorities in South Korea: Implications for HIV Prevention PolicyAIDS Patient Care and STDs · 2026
3. Safety and Effectiveness of Intravenous Belimumab in Patients with Systemic Lupus Erythematosus in South Korea: A Multicentre, Observational, Real-World StudyDrugs - Real World Outcomes · 2026
4. Disease Burden and Treatment Pattern of Advanced or Recurrent Endometrial Cancer in Korea: A Nationwide Database (DIRECTION) StudyCancer Research and Treatment · 2025
5. Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experimentHuman Vaccines & Immunotherapeutics · 2025
6. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and OlderDrug Safety · 2024
7. Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases Is Increasing in Korean Children and AdolescentsAllergy Asthma and Immunology Research · 2024
8. The Impact of an Antimicrobial Stewardship Program on Days of Therapy in the Pediatric Center: An Interrupted Time-Series Analysis of a 19-Year StudyJournal of Korean Medical Science · 2024
9. Overview of clinical study designsClinical and Experimental Emergency Medicine · 2023
10. Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)Human Vaccines & Immunotherapeutics · 2023
11. A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1Infection and Chemotherapy · 2023
12. Risk Factors of Pertussis Among Older Adults in South Korea: A Nationwide Health Data-Based Case–Control StudyInfectious Diseases and Therapy · 2023
13. An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean PatientsTuberculosis & respiratory diseases · 2022
14. Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review StudyAnnals of Dermatology · 2022
15. Safety and Effectiveness Analysis of Kivexa®(lamivudine/abacavir sulfate) in Human Immunodeficiency Virus Infected Korean PatientsInfection and Chemotherapy · 2019
16. A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in KoreaJournal of Korean Medical Science · 2019
17. Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South KoreaHuman Vaccines & Immunotherapeutics · 2018
18. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized studyHuman Vaccines & Immunotherapeutics · 2018
19. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in KoreaPharmacoEconomics · 2018
20. A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South KoreaHuman Vaccines & Immunotherapeutics · 2018